Книгопис

1.Fathalla NEF. Incessant ovulation a factor in ovarian neoplasia'? Lancet. 1971: 2:163.

2.Whittemore AS, Harris R, Itnyre J-Department of Health Research and Policy, Stanford University School of Medicine, CA. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Obstet Gynecol 1991 Jan;77(1):124-8

3.Venn A, Watson L, Bruinsma F, Giles G, Healy D -Centre for the Study of Mothers' and Children's Health, La Trobe University, Carlton, Victoria, Australia.

Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 1999 ; 254 : 1586-90.

4.Mosgaard BJ, Lidegaard O, Kjaer SK, Schou G, Andersen AN
University of Copenhagen, and Institute of Cancer Epidemiology, Danish Cancer Society. Ovarian stimulation and borderline ovarian tumors: a case-control study.

5.Risch HA Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06520-8034, USA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 1999 Apr 7;91(7):650-1
6.Bristow RE, Karlan BY Department of Obstetrics and Gynecology, University of California Los Angeles, School of Medicine, USA. Ovulation induction, infertility, and ovarian cancer risk. PMID: 8816606, UI: 96413452
7.Franceschi S, La Vecchia C, Negri E, Guarneri S, Montella M, Conti E, Parazzini F Centro di Riferimento Oncologico, Aviano (PN), Italy. Fertility drugs and risk of epithelial ovarian cancer in Italy. Hum Reprod Update 1995 Jul;1(4):428

8.Rodriguez C, Tatham LM, Calle EE, Thun MJ, Jacobs EJ, Heath CW Jr
Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA 30329-4251, USA. Infertility and risk of fatal ovarian cancer in a prospective cohort of US women. Fertil Steril 1999 May;71(5):853-9

9.Mosgaard BJ, Lidegaard O, Kjaer SK, Schou G, Andersen AN
Department of Obstetrics and Gynaecology, Herlev Hospital, University of Copenhagen, Denmark. Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. Fertil Steril 1998 Jan;69(1):168-9

10.Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG
Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994 Sep 22;331(12):805-6
11.Rosen B, Irvine J, Ritvo P, Shapiro H, Stewart D, Reynolds K, Robinson G, Thomas J, Neuman J, Murphy J Toronto Hospital, University of Toronto, Ontario, Canada. The feasibility of assessing women's perceptions of the risks and benefits of fertility drug therapy in relation to ovarian cancer risk. Fertil Steril 1996 Jan;65(1):13-8
12.Potashnik G, Lerner-Geva L, Genkin L, Chetrit A, Lunenfeld E, Porath A-Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel. Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. Am J Epidemiol 1998 Jun 1;147(11):1038-42

13.Shushan A, Paltiel O, Schenker- JGDepartment of Obstetrics and Gynecology, Hebrew University, Hadassah Medical Center, Jerusalem, Israel. Induction of ovulation and borderline ovarian cancer--the hormonal connection? Gynecol Oncol 1998 Mar;68(3):226-8